On a trail of Imbrutinib and venetoclax for CL... - CLL Support

CLL Support

23,963 members40,798 posts

On a trail of Imbrutinib and venetoclax for CLL 11q deletion. Just ramped up to 400mg of venetoclax a few weeks ago. Fatigue has kicked in.

Jonboy64 profile image
1 Reply

Is this normal because I've no real side effects up till now?

Written by
Jonboy64 profile image
Jonboy64
To view profiles and participate in discussions please or .
Read more about...
1 Reply
AdrianUK profile image
AdrianUK

It’s a lot of work for the body to kill all those cancer cells. These drugs can also directly cause fatigue. But it’s worth hanging in there. Hopefully the fatigue will pass. And if so it’s a very small price to pay if it also means your disease is being blasted!

Good luck. Fatigue is a strange thing and very variable. We all get it at some point in our illnesses I think. But we can also often find that we claw our way back out of it quicker than we think.

But if you are worried as always talk to your doctors. Remember fatigue can also represent an infection And we are at increased risk of infection during any kinds of treatment. Check your temperature. And as I say talk to your team if you have any concerns at all. That’s what they are there for. All the very best.

Not what you're looking for?

You may also like...

CLL and weakness? Fatigue just a state of mind?

CLL sources say weakness can be a CLL symptom. Is this a direct effect of CLL on muscle tissue?...
whitravis profile image

Is the combination of Imbrutinib and Venetoclax still in trial? Do you have to be in a trial to combine the two?

My husband started Imbrutinib just 3 months ago, but there was no discussion about Venetoclax as...
kathymac52 profile image

Opportunity to support the listing of Acalabrutinib and Venetoclax for the treatment of Australians with CLL

No matter where you live, you can support the access of Australians with CLL to Acalabrutinib or...
AussieNeil profile image
Partner

Venetoclax Added to Ibrutinib in High-Risk CLL Achieves a High Rate of Undetectable Minimal Residual Disease.

December 8, 2019 ASH poster. There are lots of us on long term Ibrutinib who have had a good...
Jm954 profile image
Administrator